Deguchi et al., revealed that breast cancer cells treated with EGCG show increased phosphorylation of JNK/SAPK and p38 which in turn inhibit cdc2 phosphorylation and modulate the expression of Cyclin A, Cyclin Bl, and Cdks, resulting in G2 arrest [189]. This evidence concerns the gene MAPK8 and breast carcinoma.